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METHODOLOGY
High purity high yield tandem B and T 
helper cell isolation for qRT-PCR analysis 
suitable for basically equipped laboratories
Andrea Maria Summerauer1, Lorenzo Colombo1, Rodney Ogwang2,3, Christoph Berger1, Jan Fehr4,5 
and Simone Bürgler1* 
Abstract 
Background: Malaria is still a major health problem in sub-Saharan Africa and south-east Asia, but research on 
malaria in low-income countries can be a challenge due to the lack of laboratory equipment. In addition, severe 
malaria mainly affects very young children, which limits the amount of blood available for research purposes. Thus, 
there is a need for protocols that yield a maximum of information from a minimum amount of blood, which are oper-
able in basically equipped laboratories.
Results: A protocol for tandem B and T helper (Th) cell isolation directly from whole blood, and a freezer-independ-
ent sample preservation method compatible with the warm and humid climate of malaria regions was established 
and validated. The protocol thereby circumvents the need of high-technology centrifuges and unimpeachable power 
supply for peripheral blood mononuclear cell isolation. Both purity and yield are excellent. Depending on the expres-
sion level of the genes of interest, between 2 and 5 ml of blood are adequate for reliable qRT-PCR results from both B 
and Th cells of healthy paediatric donors as well as paediatric malaria patients.
Conclusion: This protocol for high purity high yield B cell and Th cell isolation and sample storage for subsequent 
qRT-PCR analysis from a minimal amount of blood is contrivable with basic equipment and independent of continu-
ous power supply. Thus, it is likely to be of avail for many scientists performing malaria research in rural institutes or 
hospitals, and thus in countries where malaria is most prevalent.
Keywords: B and T cell isolation from whole blood, High purity, Storage, Research in resource-limited setting, Basic 
equipment, Malaria, qRT-PCR analysis
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Background
Malaria is still a major health problem in sub-Saharan 
Africa and south-east Asia. The World Health Organi-
zation (WHO) estimated 216 million new cases of 
malaria and 445,000 deaths in the year 2016 [1]. Even 
though treatment of severe malaria has improved dur-
ing the last decade, prompt administration of effective 
drugs—a prerequisite to prevent multiple organ failure 
in severe malaria—remains a major challenge in rural 
areas with long distances from the closest health cen-
tre. In addition, several Plasmodium species develop 
resistance to anti-malarials [2]. Furthermore, in cer-
tain endemic areas such as equatorial Africa, patients 
that survive malaria have an increased risk of develop-
ing (and eventually dying from) Burkitt’s lymphoma 
[3]. Thus, development of therapeutic strategies that 
prevent rather than treat malaria—such as vaccines—
are highly desirable. Unfortunately, anti-malaria vac-
cine development has turned out to be challenging. 
Even though natural infection in endemic areas results 
in immunity, this does not last indefinitely [4–6]. Fur-
thermore, the immunity provided by natural infection 
seems to be very difficult to achieve using purified 
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antigens [7]. It has been hypothesized that a malaria-
related expansion of a certain B cell subset—referred 
to as “atypical” or “exhausted” B cells—may be a reason 
for the observed deficiency in the humoral response 
that hampers development of protective antibodies 
upon vaccination [8, 9]. The enzyme activation-induced 
cytidine deaminase (AID) plays a central role in class-
switch recombination (CSR) and somatic hypermuta-
tion (SHM) [10]. AID expression in normal mature B 
cells within germinal centres is induced by T helper 
(Th)-cell derived signals such as CD40 ligation and 
cytokines [11]. Thus, for an efficient production of 
class-switched high-affinity antibodies, B cells depend 
on help from Th cells. Interestingly, a recent report pro-
vided evidence that not only B cells, but also Th cells 
may be dysfunctional in malaria patients [12]. Never-
theless, despite their importance in both malaria and 
anti-malaria vaccine development, very little is known 
about the phenotype and function of B and Th cells in 
malaria patients.
Performing malaria research in low-income coun-
tries—where malaria is most prevalent—is challenging 
and often hampered by the lack of equipment, unsta-
ble power supplies and absence of reliable cold-chains. 
In addition, severe malaria most often affects children 
under 5  years of age. Together with the fact that severe 
anaemia is one of the most common complication, this 
strictly limits the amount of blood available for research 
purpose, which hampers investigations on blood cells 
such as B and Th cells.
The importance of understanding the development, 
nature and function of lymphocytes in malaria moti-
vated us to develop a protocol for high purity, high yield 
B and Th cell isolation that is contrivable in basically 
equipped facilities and independent of high speed centri-
fuges or continuous power supply (Fig. 1). Depending on 
the expression levels of the genes of interest, 2–5  ml of 
Fig. 1 Establishment of the protocol. In a first step, tandem isolation of B cells and Th cells from whole blood was optimized and quality controlled 
for purity and efficiency by flow cytometry. Next, B cells and Th cells were isolated from small amounts of blood from healthy paediatric donors, cell 
numbers were determined and gene expression of various genes was analysed by qRT-PCR in order to determine the minimal amount of blood and 
cells necessary for reliable qRT-PCR results. Then, different preservation methods were compared under various conditions. Finally, the protocol was 
employed to analyse gene expression in B cells and Th cells from paediatric malaria patients isolated in a rural hospital in Uganda
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blood is sufficient to isolate both B and Th cells, store the 
samples at room temperature (RT) for at least 1  month 
and analyse gene expression by conventional quantitative 
real-time polymerase chain reaction (qRT-PCR).
Methods
Healthy subjects
For establishment and validation of the tandem B and Th 
cells isolation protocol, cells were isolated from blood of 
adult volunteers, and healthy children undergoing rou-
tine tonsillectomy at the University Children’s Hospital 
Zurich. All experiments were previously approved by the 
regional ethics committee (Kantonale Ethikkommision 
Zürich, KEK).
Malaria patients
Thirty four children meeting the clinical criteria for acute 
malaria [1] as well as having a positive result on a malaria 
rapid test (Binax  NOW®), were enrolled at Kitgum gen-
eral Hospital, Uganda after having obtained informed 
parental consent. All experiments were previously 
approved by the School of Medicine Research Ethics 
Committee, (SOMREC) as well as the Uganda National 
Council for Science and Technology (UNCST).
Determination of parasite load
The parasite load of all individuals that were posi-
tive for malaria on  HRP-2 RDT  testing was determined 
according to standard protocols [1]. Briefly, thick blood 
smear slides were prepared and stained following stand-
ard Giemsa-staining protocols. Each slide was examined 
by two independent observers, and differences  recon-
ciled by a third observer. The number of asexual malaria 
parasites per 200 white blood cells (WBC) was reported 
and the parasite load per µl of blood estimated, assuming 
8000 WBC/µl of blood.
Blood sampling and serum preparation
Whole blood was collected in 9  ml Heparin Sarstedt 
Monovette tubes, following the common standard of care 
recommendations [13]. Serum was prepared by centri-
fuging 1 ml of whole blood at 1000g for 5 min.
B and Th cell isolation from whole blood
The magnetic B and Th cell isolation from whole blood 
was carried out using the EasySep™ HLA Chimerism 
Whole Blood CD19 Positive Selection Kit (Stemcell 
Technologies) and the EasySep™ Human Whole Blood 
CD4 Positive Selection Kit (Stemcell Technologies) 
[14, 15]. The isolation medium was prepared by mixing 
50  ml phosphate buffered saline (PBS) (BioConcept), 
10 µl EDTA and 1 ml heat-inactivated FBS (Gibco). After 
several rounds of optimization, the following isolation 
procedure was established: The blood was collected in 
9 ml Heparin tubes and transferred to 15 ml Falcon tubes 
for the isolation, adding a maximal amount of 4.5  ml 
blood per Falcon tube. First, the blood was mixed 1:1 
with the Lysis buffer provided by the kit. Then, 25 µl per 
ml diluted blood sample of the B cell selection cocktail 
was added and samples were incubated for 5 min at RT. 
Next, 25 µl magnetic beads (rapid spheres) per ml diluted 
blood sample were added for 5 min. Afterwards, the sam-
ple volumes of ≤ 2.5 ml blood were topped up to 5 ml and 
samples volumes of > 5 ml were topped up to 10 ml with 
isolation medium. The diluted sample was incubated in 
the magnet without lid for 5 min. Importantly, instead of 
pouring off the supernatant as indicated in the manufac-
turer’s protocol, it was pipetted off with a 2  ml pipette, 
which dramatically increased the yield. This washing step 
was repeated twice, each time topping up the sample with 
5 (or 10, respectively) ml of the isolation medium. Upon 
pipetting away the third supernatant, the falcon tube 
with the enriched B cells was removed from the mag-
net and the B cells were carefully eluted with complete 
RPMI (cRPMI) medium for counting and flow cytometry 
analysis.
Th cells were isolated from the first negative fraction 
after the B cell isolation, thus the red blood cells were 
already lysed at that time-point and the lysis step was 
omitted for the Th cell isolation. The other isolation steps 
were performed as follows: 25  µl of the CD4 selection 
cocktail per ml of diluted sample were added and the 
sample was incubated for 15 min. Thereafter, 25 µl mag-
netic nanoparticles per ml diluted samples were added 
and the sample was incubated for 10 min. To reduce the 
time of isolation process, the CD4 isolation was per-
formed in parallel; i.e. the selection cocktail for the CD4 
isolation was added to the negative fraction, when the B 
cell sample was on the magnet for the second washing 
step.
Flow cytometry
To analyse the purity and efficiency of the B and Th 
cell isolation, flow cytometry analysis was performed. 
In order to identify B and Th cells, we stained for CD3 
(total T cells), CD4 (Th cells) and CD19 (B cells) using 
fluorophore-conjugated antibodies (Table  1). To control 
for background signalling and to set the gates, isotype 
Table 1 List of fluorophore-conjugated antibodies
Target Fluorophore Clone Dilution Company
CD4 FITC OKT4 1:80 eBioscience
CD19 PE HIB19 1:20 eBioscience
CD3 APC UCHT1 1:80 Biolegend
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control antibodies were used. The cells were stained in 
staining buffer [PBS (BioConcept), 2% FBS (Gibco)] and 
subsequently fixed with 4% paraformaldehyde (Sigma) for 
15 min. The cells were analysed with the BD FACSCanto 
ll flow cytometer (BD Bioscience). Data was processed 
by the BD FACSDiva software (BD Bioscience). The data 
was analysed using the FlowJo software (Treestar, Inc.).
RNA extraction and determination of RNA integrity
To optimize sample storage, two different approaches 
were tested. On one side, RNA was extracted from the 
cells using the RNEasy Mini Kit (Qiagen) and then stored 
in RNAstable. On the other side, the cells were stored in 
RNAshield™ and subsequently, RNA was isolated using 
the Quick-RNA™ Micro Prep (Zymo Research). The con-
centration of RNA was measured with the NanoDrop™ 
3300 Fluorospectrometer. To remove the remaining 
DNA, RNA was treated with DNAse (Ambion). RNA 
integrity was analysed using the Agilent Bioanalyzer 2100 
System (Agilent technology).
qRT‑PCR
Reverse transcription was performed using the Applied 
Bioscience Kit. The mRNA expression of hydroxymeth-
ylbilane synthase HMBS, glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH/GAPDH), 18sRNA [16–18]. 
CD19, AID, RAG1, IL-4 and TGF-b were analysed by 
qRT-PCR using the  TaqMan® technique with prede-
signed  TaqMan® Assays (Thermo Fisher Scientific).
Diagrams and statistics
Data was analysed using the GraphPad Prism Version 7. 
For statistical significance, one- and two-way ANOVA 
tests were applied. For assessing correlations, Spearman 
test was used.
Results
High purity tandem B cell Th cell isolation from whole 
blood using magnetic beads
Often, malaria research needs to be performed in rural 
areas without access to modern laboratory equipment. 
To enable lymphocyte cell isolation in the absence of 
continuous power supply and high-speed centrifuges, 
a power-independent protocol accomplishable at RT 
needed to be established. Most methods for B cell and 
Th cell purification start with the isolation of PMBC 
using a density gradient [19]. Since this requires both a 
high-speed centrifuge and an unimpeachable continu-
ous power supply, an approach where B and Th cells are 
isolated directly from whole blood using magnetic beads 
coupled to antibodies against surface antigens was cho-
sen. Thus, kits starting from isolated peripheral blood 
mononuclear cell (PBMC) such as MagniSort™ Human 
CD19 Positive Selection Kit [20], MojoSort™ Human 
Pan B Cell Isolation Kit [21], Miltenyi Biotec B Cell Isola-
tion Kit II, human [22] were excluded. As B cells are less 
abundant in blood than Th cells, isolation of B cells was 
prioritized and a positive isolation method that enables 
subsequent isolation of Th cells from the negative frac-
tion was selected.
Thus, the final protocol was set up using the EasySep™ 
HLA Chimerism Whole Blood CD19 Positive Selec-
tion Kit (Stemcell Technologies) for B cell isolation [14] 
with a subsequent Th cell isolation using the EasySep™ 
Human Whole Blood CD4 Positive Selection Kit (Stem-
cell Technologies) [15]. To optimize and validate this 
isolation strategy, 5 ml of blood from healthy adult indi-
viduals were used. Purity and efficacy of the isolation 
process were assessed by flow cytometry (Fig.  2). After 
several rounds of optimization, a purity of 98.3 ± 2.3% for 
the B cells and 97.8 ± 3.1% for the Th cells, and a yield of 
96.1 ± 3.0% for the B cells and 98.0 ± 2.2% for the Th cells 
was reached. Thus, both isolation steps achieved excel-
lent purities and high yield, which is of great importance 
when the available blood volume is limited.
Next, the number of B and Th cells that can be isolated 
from small amounts of blood was determined, and it was 
investigated, whether these numbers are high enough 
for reliable qRT-PCR analysis. To mimic the situation 
of paediatric malaria, 1.3–2.7 ml blood from 13 healthy 
children aged between 2 and 8 years was used to isolate 
B and Th cells with the established protocol (Fig.  3). In 
these experiments, a B cell count of 136,700/ml (95% CI 
[81,230–192,100]) and a Th cell count of 833,800/ml (95% 
CI 532,300–1,135,000]) was obtained (Fig.  3a). Expres-
sion of the housekeeping gene HBMS, but also of the B 
cell gene AID and the Th cell genes IL-4 and TGF-b was 
analysed by qRT-PCR. While Ct values for TGF-b were 
lower than 35 in all samples, the Ct values for AID were 
above 35 in almost one-third of the samples (Fig. 3b, c). 
Thus, for genes with high expression levels, 1.3–2.7  ml 
blood from healthy individuals is enough, while for other 
genes, more blood is required and/or some samples may 
need to be excluded from the analysis due to low reliabil-
ity of the qRT-PCR results.
Determination of the most suitable preservation method
In the absence of any storage reagent, RNA is degraded 
rapidly [23]. Storage of fixed whole blood is less deli-
cate, but after fixation, isolation of B and Th cells is no 
longer possible, thus gene expression cannot be attrib-
uted to a specific cell type anymore. To select a sample 
storage method independent of continuous cold chains 
that ensures RNA quality comparable to storage at 
− 80  °C, two different approaches were tested at three 
different conditions: on one side, RNA was isolated 
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from cell pellets and subsequently dehydrated using 
 RNAstable® (Biomatrica), a reagent for stabilizing and 
protecting samples from degradation based on anhy-
drobiosis [24]. On the other side, the cell pellet was 
lysed in DNA/RNA shield™ (Zymo research) and stored 
until RNA isolation [25]. In more detail, RNA derived 
from 10 × 106 RS4; 11 cells in  RNAstable® and lysate 
of 10  ×  106 RS4; 11 cells in DNA/RNA shield™ were 
stored for 1  month at (A) −  80  °C, (B) RT, and (C) at 
37 °C with a humidity of about 95% (Fig. 4). RNA qual-
ity was assessed by determination of the RNA Integrity 
Number (RIN) (Fig. 4a) as well as by qRT-PCR analysis 
of three housekeeping genes and three B cell genes 
known to be expressed at different levels (Fig. 4b). Both 
methods to examine RNA quality revealed that RNA 
quality was clearly inferior when RNA was stored for 
1 month at 37 °C as compared to storage at − 80 °C or 
RT, regardless of the preservation method (two-way 
ANOVA, all p values < 0.0001). Storage at RT resulted 
in slightly but not significantly lower RIN compared 
to storage at −  80  °C. In line with this, no significant 
changes in Ct values were observed between these two 
temperatures, which was consistent for all six genes 
analysed (Fig. 4c). Importantly, however, at 37  °C with 
a b
c d
Fig. 2 Flow cytometry analysis of purity and efficiency of B and Th cell isolation. Shown is a representative analysis of three independent isolations. 
a Flow cytometry analysis of whole blood after erythrocyte lysis (= before B cell isolation). Upper left: gating of live lymphocytes. Lower left: 
gating of single cells. Upper right: total T cells (CD3+) versus B cells (CD19+). Lower left: total T cells (CD3+) versus Th cells (CD3+CD4+). b Flow 
cytometry analysis of isolated CD19+ B cells (= positive fraction after B cell isolation). Upper left: gating of live lymphocytes. Lower left: gating 
of single cells. Upper middle: total T cells (CD3+) versus B cells (CD19+). Lower middle: total T cells (CD3+) versus Th cells (CD3+CD4+). Upper 
right: histogram of CD19 positive cells. Lower right: histogram of CD4 positive cells. c Flow cytometry analysis of isolated CD4+ Th cells (= positive 
fraction after Th cell isolation). Upper left: gating of live lymphocytes. Lower left: gating of single cells. Upper middle: total T cells (CD3+) versus B 
cells (CD19+). Lower middle: total T cells (CD3+) versus Th cells (CD3+CD4+). Upper right: histogram of CD19 positive cells. Lower right: histogram 
of CD4 positive cells. d Flow cytometry analysis of the negative fraction after Th cell isolation. Upper left: gating of live lymphocytes. Lower left: 
gating of single cells. Upper middle: total T cells (CD3+) versus B cells (CD19+). Lower middle: total T cells (CD3+) versus Th cells (CD3+CD4+). 
Upper right: histogram of CD19 positive cells. Lower right: histogram of CD4 positive cells
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high humidity, the DNA/RNA shield™ protected the 
RNA slightly but consistently better from degradation 
than the  RNAstable® (Fig.  4a, b). This may be due to 
the fact that the humidity lead to a partial rehydration 
of the RNA. Even with increased efforts of keeping the 
samples dry in the incubator (adding desiccant packs 
and sealing the tubes with paraffin film), RNA samples 
in  RNAstable® kept at 37 °C in the incubator displayed 
a higher degree of RNA degradation than the cell sam-
ples lysed in DNA/RNA shield™.
Rural health centres often experience power cuts, which 
may lead to a temporal increase in storage temperatures 
even in the presence of freezers, fridges or air condition. 
Similarly, samples may suffer from a transient increase in 
temperature during transportation. To address the impact 
of such short-term temperature changes, RNA samples 
a
b
c
Fig. 3 Cell number and Ct value analysis after B and Th cell isolation from whole blood of healthy paediatric donors. Blood was withdrawn from 
13 healthy paediatric donors, B and Th cells were isolated and gene expression of AID, IL-4, TGF-b as well as the housekeeping gene HMBS was 
analysed by qRT-PCR. a B cell and Th cell numbers per ml of blood. b Amounts of blood withdrawn versus Ct values of HMBS (green), AID (red), 
IL-4 (orange) and TGF-b (blue). Symbol shapes indicate three different age groups. c Table summarizing parameters related to donors, B and Th cell 
isolation and gene expression analysis
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stored in RNAshield for 7 days were incubated at differ-
ent temperatures and a 1-day power disruption simulated, 
followed by determination of RIN and Ct values of six 
genes (Fig. 4d). RNA of samples stored at − 80 °C showed 
only a slight decrease in integrity when brought to 4  °C, 
irrespective of whether the RNA was refrozen afterwards 
or kept unfrozen at 4 °C for 7 days. A similar RNA qual-
ity was observed for samples stored continuously at 4 °C, 
warmed-up for a short period to RT or kept at RT for the 
whole period of 14 days. Importantly, however, short-term 
warm-up to 37 °C clearly deteriorated the RNA integrity, 
even though not as dramatically as when the samples were 
stored at 37 °C for 14 days.
Together, this suggests that freezers are not absolutely 
required for medium term sample storage, but sam-
ples are preferably stored in a fridge or a in an air-con-
ditioned room when the environmental temperatures 
are above 25  °C. Most importantly, in warm and humid 
environments, preservation of the cell pellet in DNA/
RNA shield™ is preferred over dehydration of RNA using 
 RNAstable®.
Expression of AID, IL‑4 and TGF‑b in B and Th cells 
from malaria patients
Finally, the protocol established above was used to 
investigate possible reasons for the impaired antibody 
response in malaria. Given the key role of AID in the 
generation of high affinity antibodies, it may be hypoth-
esised that at a high parasite count, up-regulation of 
AID is inhibited, which in turn leads to a defective anti-
body response. To address whether malaria patients with 
high parasite count express lower levels of AID than 
those with a low count, B cells and Th cells were isolated 
from malaria patients and stored in RNAshield for up to 
1  month at −  20  °C. Then, samples were shipped from 
Kitgum to Kampala (approximately 12 h in cooling bags), 
stored for 48 h at 4 °C and finally shipped to Switzerland 
(approximately 20 h with cooling bags), where RNA was 
isolated and gene expression was analysed by qRT-PCR 
(Fig.  5). Tandem B and Th cell isolation from 2 to 5  ml 
of blood as established above yielded 0.2–6.7 mio B cells 
(2.3 ± 3.4) and 0.8–22 mio Th cells (4.5 ± 4.4, Fig. 5a). As 
previously reported [26], younger children had more B 
and Th cells (Fig. 5b). With the exception of two B cells 
samples, Ct values were below 35, suggesting that the iso-
lation and storage method described above was very well 
suited for analysis of AID expression in B cells isolated 
from a small amount of blood (Fig.  5a, c). Since TGF-b 
and IL-4 are the main cytokines that induce AID expres-
sion [11], their expression levels in Th cells of malaria 
patients were analysed. Ct values of these cytokines were 
well below 35 except in one sample. Then, the parasite 
load was correlated with expression of AID, TGF-b and 
IL-4 (Fig.  5d, e). Even though the highest expression of 
AID, IL-4 and TGF-b was indeed observed in patients 
with low parasite count, there was no significant correla-
tion between parasite count and these genes.
Taken together, while no correlation between high par-
asite count and low AID expression was found, the proto-
col established here was clearly suitable for gene analysis 
by qRT-PCR in B cells and Th cells isolated from small 
amounts of blood from paediatric malaria patients.
Discussion
This study presents a protocol for high purity B cell and 
Th cell isolation and medium-term sample storage for 
standard qRT-PCR analysis from small amounts of blood 
that is contrivable in basically equipped laboratories.
Fig. 5 Expression of AID, IL-4 and TGF-b in B and Th cells from malaria patients. Blood was drawn from 34 patients diagnosed with malaria, B and Th 
cells were isolated and gene expression of AID, IL-4, TGF-b as well as the housekeeping gene HMBS was analysed by qRT-PCR. a Table summarizing 
parameters related to donors, B and Th cell isolation and gene expression analysis. b Age of the patients versus number of cells isolated. c Amount 
of blood withdrawn versus Ct values of HMBS (green), AID (red), IL-4 (orange) and TGF-b (blue). Symbol shapes indicate three different age groups. d 
Correlation of AID expression in B cells with parasite load. e Correlation of IL-4 and TGF-b expression in Th cells with parasite load
(See figure on next page.)
(See figure on previous page.)
Fig. 4 Evaluation of different preservation methods at various conditions. a, b A pellet of 10 × 106 cells or RNA of 10 × 106 cells, respectively, 
was stored as indicated (x-axis) for 1 month. a RIN were determined for every condition. Shown are individual data points, mean and SD of three 
experiments. b Ct values (y-axis) of three housekeeping genes and three B cell genes were measured by qRT-PCR for every condition. Shown are 
individual data points, mean and SD of three experiments. c Mean Ct values of three housekeeping genes and three B cell genes measured in 
samples stored in RNAstable (left panel) or RNAshield (right panel) at − 80 °C were correlated to the mean Ct values of the same genes stored at 
RT. d Upper left panel: schematic representation of sample storage and simulation of transient power disruption with corresponding estimated 
temperatures: samples were stored in RNAshield at either − 20 °C (black), 4 °C (red), 25 °C (blue) or 37 °C (green). At day 7, a power disruption was 
simulated for some of the samples (dotted lines) but not for other (solid lines), and at day 8, samples were placed back to their original storage 
temperature, except for sample c (dashed line). Lower left panel: RIN were determined for every condition. Shown are individual data points, mean 
and SD of three experiments. Right panel: Ct values (y-axis) of three housekeeping genes and three B cell genes were determined by qRT-PCR for 
every condition. Shown are individual data points, mean and SEM of three experiments
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PBMC isolation on a density gradient requires a 
sophisticated centrifuge that is able to slowly and steadily 
increase the speed from 0 to 800 g and back to 0 g. Thus, 
any power cut as they frequently happen in rural areas—
would cause a sudden stop of the centrifuge. As a conse-
quence, the density gradient is disturbed and the samples 
are lost. By using tandem B and Th cell isolation directly 
from blood, the need for such a centrifuge and continu-
ous power supply could be circumvented. Furthermore, 
the protocol described here is independent from ice, it 
is fast (1–2.5 h, depending on the amount of blood and 
number of magnets available), easy to learn and to per-
form, and it yields excellent purities. The fact that the 
number of isolated cells has been consistent between the 
experiments further demonstrates its reproducibility and 
robustness. One caveat of the protocol is the fact that 
positive selection conducted at RT may activate the cells 
and therefore affect gene expression. Nevertheless, the 
protocol is relatively fast. Thus, the time from a potential 
activation until the cells are lysed is short, and a substan-
tial de novo mRNA synthesis is not expected. A further 
downside of the method is the cost of the magnetic beads 
with a price of around 44 USD for each B cell isolation 
from 4 ml whole blood, and a one-time cost for the mag-
net of 1140 USD. Still, other positive B cell isolation kits 
from whole blood such as the Dynabeads™ CD19 Pan 
B kit [27] or the Miltenyi Biotec MACSprep Chimer-
ism CD19 MicroBeads human kit [28] reside within the 
same price range with 36–60 USD per isolation and a 
magnet cost between 1076 USD and 13,200 USD. Less 
expensive is negative and positive B cell selection from 
previously isolated PBMC with about 1.6–4.4 USD/iso-
lation and a magnet prize between 826 and 2400 USD 
(e.g. MagniSort™ Human CD19 Positive Selection Kit, 
[20]. MojoSort™ Human Pan B Cell Isolation Kit [21], 
Miltenyi Biotec B Cell Isolation Kit II, human [22]). How-
ever, it has to be considered that these latter kits require 
strong and continuously running centrifuges, additional 
reagents for a density gradient, such as a Ficoll (cost per 
around 1.5 USD/4 ml whole blood sample), and are more 
time-consuming. Furthermore, funding bodies are gener-
ally more compliant to fund expenditure than equipment 
of remaining value.
In this study, 2–5 ml blood of malaria patients was used 
to analyse gene expression in B and Th cells. 4–5  ml of 
blood is an amount that is not negligible in little chil-
dren. The results of this study show that except from 
one sample, even 2–3 ml blood was sufficient for reliable 
gene expression analysis of various genes (Fig.  5c), and 
higher amounts did not substantially improve the Ct val-
ues. Nevertheless, the number of B cells in the blood is 
highly dependent on the age of the donor and may devi-
ate dramatically from the average in particular diseases 
settings, such as leukopenia in severe malaria. Thus, the 
amount of blood required not only depends on the genes 
to be investigated, but also on the donors. The results of 
this study reporting cell numbers and Ct values obtained 
from different amounts of blood from healthy and sick 
children of different age groups therefore provide infor-
mation that can help investigators to choose an appropri-
ate amount of blood for a given study.
While no marked differences between the two sample 
storage approaches were observed at −  80  °C and RT, 
preservation of the cell pellet in DNA/RNA shield™ was 
slightly but consistently superior to preservation of RNA 
in  RNAstable® at 37  °C and a high humidity, where the 
RNA may get rehydrated. Thus, in warm and humid envi-
ronments typical for malaria regions, storage of the pellet 
in DNA/RNA shield™ is preferred. Furthermore, usage of 
DNA/RNA shield™ enables deferral of the RNA extrac-
tion to any suitable time-point, allowing for transport 
of the samples to a laboratory equipped for RNA isola-
tion and further downstream analysis. Finally, it is sig-
nificantly less expensive (DNA/RNA shield™ approx. 0.7 
USD for 1 sample,  RNAstable® 2.7 USD per sample).
RNA stored in RNAshield at RT was of sufficient qual-
ity for the application of this study. Nevertheless, it needs 
to be considered that different RNAs degrade with dif-
ferent speed. Thus, even though the correlation of the Ct 
values between samples stored at RT and − 80 was close 
to 1 in the six genes analysed here, performing RNA-seq 
analysis may provide a more comprehensive validation of 
the suitability of the storage condition.
No correlation between parasite load and AID, IL-4, 
or TGF-b expression was observed. While it is certainly 
possible that these factors in fact do not correlate, a 
potential correlation may have been missed for technical 
reasons such as wrong time point of measurement, too 
small samples size or too few patients with high parasite 
load. Moreover, parasite load was only estimated by the 
use of light microscopy, and a more accurate method for 
parasite quantification such as qRT-PCR may lead to a 
different result.
Nevertheless, the protocol presented here for tandem B 
and Th cell isolation proved to be suitable for gene analy-
sis by qRT-PCR in B cell and Th cell isolated form small 
amounts of blood from paediatric malaria patients.
Conclusion
The protocol described here delineates a fast and efficient 
way of high purity B and Th cells isolation and storage 
from a minimal amount of blood in a resource limited 
environment. Even though isolation of lymphocytes from 
whole blood using magnetic beads is not a new concept 
in itself, an optimized and detailed protocol for tandem B 
and T cell isolation from as little as 2–5 ml blood has not 
Page 11 of 11Summerauer et al. Malar J          (2018) 17:395 
been available so far. The excellent purity of the isolated 
cells, the simplicity and reproducibility of the procedure 
and the fact that it can be conducted without any major 
laboratory equipment makes it a valuable tool to investi-
gate the role of B cells and Th cells in malaria, which ulti-
mately may lead to the development of novel therapeutic 
strategies.
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